Purchase Order N0025921P0400
Award Date
9/20/21
Potential Completion Date
9/19/22
Potential Value
$206K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Bureau of Medicine and Surgery
Awardee
Cardinal Health 414, LLC
Ultimate Awardee
Cardinal Health, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67. The contract has a ceiling value of $85,623.60 and a period of performance through September 30, 2016. Cardinal Health 414 is a subsidiary of Cardinal Health, Inc. and specializes in providing radiopharmaceuticals and related...
This federal contract award is for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The $249,466.62 firm fixed-price purchase order was awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has an ultimate completion date of September 30, 2026. Cardinal Health 414 is a well-established provider of critical medical isotopes and radiopharmaceutical products used in nuclear medicine, oncology, and...
This federal contract award was made by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $537,527.30 firm fixed-price purchase order is for the supply of radiopharmaceuticals, including Tc-99m, I-123, I-131, In-111, Tl-201, F-18 FDG, and Ga-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an ultimate completion date of September 30, 2027. This award is not set...
This contract award is for the supply of radiopharmaceuticals to the Defense Health Agency (DHA), a component of the Department of Defense (DoD). The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company specializing in the distribution of pharmaceuticals and medical products. The contract has a ceiling value of $738,865.37 and is structured as a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) contract. The...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including radioactive isotopes, diagnostic imaging agents, nuclear medicine supplies, and specialty pharmaceuticals. The potential value of the contract is $145,418.67, with a completion date of September 30, 2021. Cardinal Health 414 has an established track record of delivering these...
This is a federal contract award from the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, which are radioactive isotopes used in medical imaging and treatment. The contract has a ceiling value of $563,789.91 and a performance period through September 30, 2026. It is structured as a delivery order, with a firm fixed-price pricing type. The contract does not have a set-aside designation,...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the delivery of radiopharmaceutical supplies. The contract, valued at $358,406.52, was awarded by the Defense Health Agency (DHA) and has an ultimate completion date of October 1, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialized pharmaceutical products...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price delivery order contract to Cardinal Health 414, LLC for the provision of radiopharmaceuticals. The $131,945.51 contract does not have a set-aside designation and is scheduled to be completed by September 30, 2019. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc. The company has previously held indefinite delivery vehicle (IDV) contracts to supply...
This federal contract award is for the supply of radiopharmaceuticals to the Defense Health Agency, a component of the Department of Defense. The prime contractor is Cardinal Health 414, LLC, a subsidiary of the larger healthcare company Cardinal Health, Inc. The contract has a ceiling value of $375,000.00 and a performance period through September 30, 2024. It is a Blanket Purchase Agreement (BPA) call order, with a firm fixed-price pricing type. The contract does not have a set-aside...
This $955,499.55 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an...